Global Bovine Respiratory Disease Treatment Market to Grow at a CAGR of 11.5% During the Period 2024-2032, Driven by Need to Effectively Treat the Condition

The global bovine respiratory disease treatment market is expected to be driven by the need to effectively treat bovine respiratory disease and reduce the associated economic burden and number of deaths. North America and Europe are expected to be key markets.

Ill health, microbes such as bacteria and viruses, and environmental stress could render young calves prone to infections causing bovine respiratory disease. Severe infections generally cause pneumonia. In Europe and USA, bovine respiratory disease causes significant economic losses and cattle deaths. Respiratory diseases account for a greater number of deaths in young growing cattle as compared to other ailments. All respiratory viruses are spread through close animal proximity (through air). An infected animal is more likely to contract secondary bacterial infections which may severely damage animal health and farm profitability.

Continual research is being carried out to develop novel solutions. Developments in the domain are expected to boost the global bovine respiratory disease treatment market. For example, in 2022, it was reported that a study by Agri-Food and Biosciences Institute (AFBI), Teagasc and the University of Missouri revealed particular genetic markers associated with the immune response in cattle infected with viruses linked with bovine respiratory disease. Further, the study recognized how the information could be employed to make better selection of animals (choose animals with greater resistance to infection). The genetic markers in infected animals could be identified in blood cells (even when the ailment would not appear clinically) which increased the chances of the development of a diagnostic test that could determine bovine respiratory disease in cattle before they fell ill.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Findings of the Report:

• The global bovine respiratory disease treatment market is expected to be driven by the need to effectively treat the condition.

• New developments in research are expected to boost market growth.

• North America and Europe are projected to be key markets.

Market Analysis by Disease Type, Drug Type, End Use and Region:

• By disease type, the market is segmented into Pneumonia (Lower Respiratory Tract Infections), Upper Respiratory Tract Infections, and Diphtheria.

• By drug type, the market is divided into Antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Vaccines, Immunomodulators, and Others.

• By end use, the market is classified into Veterinary Hospitals, Veterinary Clinics, and Others.

• By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790